Treace Medical Concepts (TMCI) News Today $9.37 -0.29 (-3.00%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$9.64 +0.27 (+2.84%) As of 02/21/2025 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Treace Medical Concepts (TMCI) Expected to Announce Quarterly Earnings on ThursdayTreace Medical Concepts (NASDAQ:TMCI) will be releasing earnings after the market closes on Thursday, February 27, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=435653)February 20 at 1:26 AM | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Rating of "Hold" by AnalystsFebruary 14, 2025 | americanbankingnews.comInsider Stock Buying Reaches US$7.31m On Treace Medical ConceptsFebruary 8, 2025 | finance.yahoo.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Recommendation of "Hold" by AnalystsTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has earned a consensus rating of "Hold" from the seven brokerages that are covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation and two have given a buy recommendationFebruary 7, 2025 | marketbeat.comTreace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025February 6, 2025 | globenewswire.comWhy Treace Medical Concepts (TMCI) Is Rallying TodayFebruary 5, 2025 | msn.comTreace Medical Concepts (NASDAQ:TMCI) Shares Gap Up - Should You Buy?Treace Medical Concepts (NASDAQ:TMCI) Shares Gap Up - Here's What HappenedFebruary 4, 2025 | marketbeat.comTreace Medical upgraded to Buy from Neutral at BTIGFebruary 4, 2025 | markets.businessinsider.comBTIG raises Treace Medical stock to Buy, sets $16 targetFebruary 4, 2025 | msn.comPositive Report for Treace Medical Concepts (TMCI) from BTIGFebruary 4, 2025 | markets.businessinsider.comTreace Medical Concepts (NASDAQ:TMCI) Stock Rating Upgraded by BTIG ResearchBTIG Research raised shares of Treace Medical Concepts from a "neutral" rating to a "buy" rating and set a $16.00 price objective for the company in a research report on Tuesday.February 4, 2025 | marketbeat.comTreace Medical announces completion of first cases using SpeedAkin ACIJanuary 30, 2025 | markets.businessinsider.comTreace Announces First Surgical Cases Utilizing the SpeedAkin™ Anatomic Compression ImplantJanuary 30, 2025 | markets.businessinsider.comTreace Medical Concepts (NASDAQ:TMCI) Shares Up 5.1% - Time to Buy?Treace Medical Concepts (NASDAQ:TMCI) Trading Up 5.1% - Time to Buy?January 27, 2025 | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Purchased by Barclays PLCBarclays PLC boosted its position in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 352.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 79,696 shares of the company's stock after purchasing an additional 62,073 shares during tJanuary 19, 2025 | marketbeat.comJPMorgan Chase & Co. Has $7.32 Million Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)JPMorgan Chase & Co. raised its holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 215.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,262,235 shares of the company's stock after buying an additionalJanuary 15, 2025 | marketbeat.comTruist Financial Reaffirms Their Hold Rating on Treace Medical Concepts (TMCI)January 15, 2025 | markets.businessinsider.comLake Street Sticks to Its Buy Rating for Treace Medical Concepts (TMCI)January 14, 2025 | markets.businessinsider.comTreace Medical Concepts (TMCI) Receives a Hold from Stifel NicolausJanuary 14, 2025 | markets.businessinsider.comTreace Medical Preliminary Q4, FY24 Revenues Beat Expectations; Stock UpJanuary 13, 2025 | markets.businessinsider.comTreace Medical Concepts (NASDAQ:TMCI) Stock Price Up 10.3% - Still a Buy?Treace Medical Concepts (NASDAQ:TMCI) Stock Price Up 10.3% - What's Next?January 13, 2025 | marketbeat.comTreace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 RevenueJanuary 13, 2025 | markets.businessinsider.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Recommendation of "Hold" by BrokeragesTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has received an average recommendation of "Hold" from the seven analysts that are presently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a hold rating and one has issued a buy rating on the cJanuary 13, 2025 | marketbeat.comThe Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of InvestorsJanuary 9, 2025 | businesswire.comTreace to Present at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 2, 2025 | globenewswire.comLake Street Initiates Coverage of Treace Medical Concepts (TMCI) with Buy RecommendationJanuary 1, 2025 | msn.comTreace Medical Concepts (NASDAQ:TMCI) Coverage Initiated by Analysts at Lake Street CapitalLake Street Capital started coverage on Treace Medical Concepts in a research report on Tuesday. They issued a "buy" rating and a $14.50 price target for the company.December 31, 2024 | marketbeat.comTreace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® ProcedureDecember 30, 2024 | globenewswire.comWith 54% institutional ownership, Treace Medical Concepts, Inc. (NASDAQ:TMCI) is a favorite amongst the big gunsDecember 29, 2024 | uk.finance.yahoo.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Rating of "Hold" from BrokeragesTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has received a consensus recommendation of "Hold" from the six brokerages that are covering the company, Marketbeat Ratings reports. Six analysts have rated the stock with a hold rating. The average twelve-month price objective among anDecember 19, 2024 | marketbeat.comDeep Dive Into Treace Medical Concepts Stock: Analyst Perspectives (4 Ratings)December 18, 2024 | benzinga.comTruist Financial Forecasts Strong Price Appreciation for Treace Medical Concepts (NASDAQ:TMCI) StockTruist Financial increased their price objective on Treace Medical Concepts from $7.00 to $8.40 and gave the company a "hold" rating in a research report on Wednesday.December 18, 2024 | marketbeat.comTreace Medical assumed with a Neutral at JPMorganDecember 18, 2024 | markets.businessinsider.comTreace Medical Concepts' (TMCI) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co.JPMorgan Chase & Co. reiterated a "neutral" rating and set a $8.00 price objective on shares of Treace Medical Concepts in a research report on Tuesday.December 17, 2024 | marketbeat.comTreace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ ImplantDecember 16, 2024 | globenewswire.comTMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law FirmDecember 11, 2024 | prnewswire.comThe Schall Law Firm Urges Stockholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For FraudDecember 5, 2024 | stockhouse.comTreace announces cases using RedPoint Intelliguide PSI with AdductoplastyDecember 5, 2024 | markets.businessinsider.comTreace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot DeformitiesDecember 4, 2024 | globenewswire.comTreace Appoints Guy Guglielmino as Chief Commercial OfficerDecember 2, 2024 | globenewswire.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Recommendation of "Hold" by BrokeragesTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has earned an average recommendation of "Hold" from the six ratings firms that are presently covering the stock, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold rating. The average 12-month prNovember 24, 2024 | marketbeat.comTMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law FirmNovember 22, 2024 | prnewswire.comTreace Medical Concepts, Inc. Is Being Investigated For Fraud And Investors With Losses Are Invited To Contact The Schall Law FirmNovember 21, 2024 | stockhouse.comTreace Announces Participation at Stifel 2024 Healthcare ConferenceNovember 18, 2024 | globenewswire.comTMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law FirmNovember 12, 2024 | prnewswire.comAnalysts Offer Insights on Healthcare Companies: Treace Medical Concepts (TMCI), MacroGenics (MGNX) and Novo Nordisk (NVO)November 7, 2024 | markets.businessinsider.comMorgan Stanley Sticks to Its Hold Rating for Treace Medical Concepts (TMCI)November 7, 2024 | markets.businessinsider.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | insidermonkey.comTreace Medical Concepts Inc (TMCI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...November 6, 2024 | finance.yahoo.comTreace Medical Concepts Reports Strong Q3 2024 GrowthNovember 6, 2024 | markets.businessinsider.com Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address TMCI Media Mentions By Week TMCI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TMCI News Sentiment▼0.000.60▲Average Medical News Sentiment TMCI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TMCI Articles This Week▼13▲TMCI Articles Average Week Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Enovis News NovoCure News TransMedics Group News LeMaitre Vascular News Tandem Diabetes Care News Soleno Therapeutics News CONMED News Cadre News Liquidia News InMode News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TMCI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.